Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica E Sutherland

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Molecular Therapy. Nucleic Acids|July 1, 2015
Onset Time and Durability of Huntingtin Suppression in Rhesus Putamen After Direct Infusion of Antihuntingtin siRNARichard Grondin, Pei Ge, Qingmin Chen, et al.
Lancet (London, England)|October 8, 2013
Effect of an RNA interference drug on the synthesis of proprotein convertase subtilisin/kexin type 9 (PCSK9) and the concentration of serum LDL cholesterol in healthy volunteers: a randomised, single-blind, placebo-controlled, phase 1 trialKevin Fitzgerald, Maria Frank-Kamenetsky, Svetlana Shulga-Morskaya, et al.
Nucleic Acids Research|March 2, 2019
Safety evaluation of 2'-deoxy-2'-fluoro nucleotides in GalNAc-siRNA conjugatesMaja M Janas, Ivan Zlatev, Ju Liu, et al.
Nature Biotechnology|June 2, 2022
Expanding RNAi therapeutics to extrahepatic tissues with lipophilic conjugatesKirk M Brown, Jayaprakash K Nair, Maja M Janas, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Molecular Therapy. Nucleic Acids|July 1, 2015
Onset Time and Durability of Huntingtin Suppression in Rhesus Putamen After Direct Infusion of Antihuntingtin siRNARichard Grondin, Pei Ge, Qingmin Chen, et al.
Lancet (London, England)|October 8, 2013
Effect of an RNA interference drug on the synthesis of proprotein convertase subtilisin/kexin type 9 (PCSK9) and the concentration of serum LDL cholesterol in healthy volunteers: a randomised, single-blind, placebo-controlled, phase 1 trialKevin Fitzgerald, Maria Frank-Kamenetsky, Svetlana Shulga-Morskaya, et al.
Nucleic Acids Research|March 2, 2019
Safety evaluation of 2'-deoxy-2'-fluoro nucleotides in GalNAc-siRNA conjugatesMaja M Janas, Ivan Zlatev, Ju Liu, et al.
Nature Biotechnology|June 2, 2022
Expanding RNAi therapeutics to extrahepatic tissues with lipophilic conjugatesKirk M Brown, Jayaprakash K Nair, Maja M Janas, et al.
Pageof 2